Time Table - 165 attended

Thursday 5th December 2013

18.00 Registration begins
Informal refreshments
20.00 Dinner - choose your table by subject

Friday 6th December 2013

8.00 Registration begins
8.30 Welcome, David Noakes, CEO, Immuno Biotech Ltd, and
Dr Mohammed Abuelkhair, former Head, Medical Product Regulation, HAAD, UAE

Advances in the science
8.40   Professor Marco Ruggiero: GcMAF: From molecular modelling to clinical practice.
9.20   Professor Ra’ed Abu Odeh PhD, University of Sharjah UAE
10.00 Dr Rod Smith PhD: Activity assays - Histology of GcMAF destroying cancer cells

10.30 Coffee

Clinical results and synergistic treatments

10:50 Dr Zoya Voitenko ND, Canada: Clinical results from the new GcMAF molecules

11.30 Gail Harding: from terminal stage 4 to cancer free

 

12.15 Friday Prayers

13.00 Lunch

14.00 Dr Martin Stoppler MD: 103 clinical results from GcMAF
14.40 Dr Steven Hofman MD: 34 clinical results and core-psychiatry

15.20 Cancer workshop starts
15.20 Dr Judy Mikovits PhD: Cellular and molecular biology
16:00 Coffee
16.20 Dr Emar Vogellar PhD: Nagalase and nutritonal tests of the immune system
17.00 Jo-anne Spinks: From two months to live to cancer free in a year
Informal refreshments

18.30 Dinner - choose your table by subject

Saturday 7th December 2013

GcMAF and neurology
9.00 Professor Ruggiero PhD: ME/CFS and autism
9.40 Dr Gabriele Morucci and Dr Jacopo Branca: Neuroprotective effects of GcMAF
10.20 Dr Graham Simpson, Chief Medical Officer, Eternity Medicine, Dubai
10.50 Steve Cronin, CEO Om Life, Dubai: Hyperbaric oxygen therapy 

11.20 Coffee

GcMAF and autism
11.40 Dr Jeffrey Bradstreet MD: GcMAF and autism
12.20 Dr Mohammad Almomani, Jordan

13.00 Lunch

14.00 Dr Antonucci, Italy: 400 clinical results with GcMAF
14.40 Professor Cem Kinaci MD: Complementary and new treatments in autism
15.20 Parents of a no longer autistic child from Sharjah
15.30 Coffee

15.50 Autism workshop starts

15.50 Dario Siniscalco: Autism in the laboratory
16.30 Professor Ruggiero: The instant effects of GcMAF on the brain, with scans on volunteers
17.10 David Noakes: GcMAF results by disease. Effective treatment of stage 4
17.20 Final list of synergistic treatments, conclusions

18.00 End of Conference

18.30 Dinner for the Diehards: vote on hotel or an external restaurant

After the conference, on the 8th and 9th December there will be two days of training for doctors:

A course on cerebral ultrasonography in the diagnosis, follow-up and treatment of neurological diseases ranging from autism to neurodegenerative conditions.